/
Company Overview Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for p…
11.75% operating margin is respectable but not wide. ROIC at 6.04%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue declined 2.0% YoY. Margins deteriorated 4.6pp alongside, both lines moving the wrong way.
ROIC dropped from 9.01% to 6.04%, capital efficiency is deteriorating. Operating margin contracted 4.6pp YoY, cost discipline may be slipping.
Profitability & Returns
Revenue (TTM)
$1.33B
▼ -2.0% YoY
Net Income (TTM)
$97M
▼ -42.0% YoY
Op. Margin
11.75%
▼ -4.6pp YoY
ROIC
6.04%
▼ -3.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$260M
▲ +82.8% YoY
Op. Cash Flow (TTM)
$293M
▲ +61.4% YoY
Net Debt
$1.03B
Cash & Equiv.
$245M
5Y CAGR: +8.9%
5Y CAGR: +29.4%
Continue Research